These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 37942959)

  • 1. Improvement in Inhalation Properties of Theophylline and Levofloxacin by Co-Amorphization and Enhancement in Its Stability by Addition of Amino Acid as a Third Component.
    Ueda H; Hirakawa Y; Miyano T; Nakayama Y; Hatanaka Y; Uchiyama H; Tozuka Y; Kadota K
    Mol Pharm; 2023 Dec; 20(12):6368-6379. PubMed ID: 37942959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amino acids as stabilizers for spray-dried simvastatin powder for inhalation.
    Lu W; Rades T; Rantanen J; Chan HK; Yang M
    Int J Pharm; 2019 Dec; 572():118724. PubMed ID: 31678523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and characterization of spray-dried co-amorphous drug-amino acid salts.
    Jensen KT; Blaabjerg LI; Lenz E; Bohr A; Grohganz H; Kleinebudde P; Rades T; Löbmann K
    J Pharm Pharmacol; 2016 May; 68(5):615-24. PubMed ID: 26245703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved Physical Stability and Aerosolization of Inhalable Amorphous Ciprofloxacin Powder Formulations by Incorporating Synergistic Colistin.
    Shetty N; Ahn P; Park H; Bhujbal S; Zemlyanov D; Cavallaro A; Mangal S; Li J; Zhou QT
    Mol Pharm; 2018 Sep; 15(9):4004-4020. PubMed ID: 30028947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-amorphous systems consisting of indomethacin and the chiral co-former tryptophan: Solid-state properties and molecular mobilities.
    Holzapfel K; Rades T; Leopold CS
    Int J Pharm; 2023 Apr; 636():122840. PubMed ID: 36921746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhalable ceftazidime-roflumilast powder targeting infection and inflammation: Influence of incorporating roflumilast into ceftazidime-leucine co-amorphous formulation.
    Raj Adhikari B; Sinha S; Lyons N; Pletzer D; Lamont I; Gordon KC; Das SC
    Eur J Pharm Biopharm; 2022 Nov; 180():260-268. PubMed ID: 36241076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spray dried inhalable ivacaftor co-amorphous microparticle formulations with leucine achieved enhanced in vitro dissolution and superior aerosol performance.
    Guan J; Yuan H; Yu S; Mao S; Tony Zhou Q
    Int J Pharm; 2022 Jun; 622():121859. PubMed ID: 35643348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amino acids improve aerosolization and chemical stability of potential inhalable amorphous Spray-dried ceftazidime for Pseudomonas aeruginosa lung infection.
    Adhikari BR; Sinha S; Gordon KC; Das SC
    Int J Pharm; 2022 Jun; 621():121799. PubMed ID: 35525472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation of Co-Amorphous Levofloxacin Systems for Pulmonary Application.
    Gabelmann A; Lehr CM; Grohganz H
    Pharmaceutics; 2023 May; 15(6):. PubMed ID: 37376022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of variation in molar ratio on co-amorphous drug-amino acid systems.
    Jensen KT; Larsen FH; Löbmann K; Rades T; Grohganz H
    Eur J Pharm Biopharm; 2016 Oct; 107():32-9. PubMed ID: 27368747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a novel dry powder inhalation formulation for the delivery of rivastigmine hydrogen tartrate.
    Simon A; Amaro MI; Cabral LM; Healy AM; de Sousa VP
    Int J Pharm; 2016 Mar; 501(1-2):124-38. PubMed ID: 26836711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sinapic Acid Co-Amorphous Systems with Amino Acids for Improved Solubility and Antioxidant Activity.
    Garbiec E; Rosiak N; Tykarska E; Zalewski P; Cielecka-Piontek J
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (Co-)amorphization of enantiomers - Investigation of the amorphization process, the physical stability and the dissolution behavior.
    Holzapfel K; Liu J; Rades T; Leopold CS
    Int J Pharm; 2022 Mar; 616():121552. PubMed ID: 35131351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amino acids as co-amorphous stabilizers for poorly water soluble drugs--Part 1: preparation, stability and dissolution enhancement.
    Löbmann K; Grohganz H; Laitinen R; Strachan C; Rades T
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):873-81. PubMed ID: 23537574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhalable co-amorphous budesonide-arginine dry powders prepared by spray drying.
    Lu W; Rades T; Rantanen J; Yang M
    Int J Pharm; 2019 Jun; 565():1-8. PubMed ID: 30999050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physico-Chemical Properties, Aerosolization and Dissolution of Co-Spray Dried Azithromycin Particles with L-Leucine for Inhalation.
    Mangal S; Nie H; Xu R; Guo R; Cavallaro A; Zemlyanov D; Zhou QT
    Pharm Res; 2018 Jan; 35(2):28. PubMed ID: 29374368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-former selection for co-amorphous drug-amino acid formulations.
    Kasten G; Löbmann K; Grohganz H; Rades T
    Int J Pharm; 2019 Feb; 557():366-373. PubMed ID: 30578980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-salt based co-amorphous formulation produced by freeze-drying.
    Suleiman Alsalhi M; Royall PG; Al-Obaidi H; Alsalhi A; Cilibrizzi A; Chan KLA
    Int J Pharm; 2023 Oct; 645():123404. PubMed ID: 37714312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-Amorphous Formation of High-Dose Zwitterionic Compounds with Amino Acids To Improve Solubility and Enable Parenteral Delivery.
    Zhu S; Gao H; Babu S; Garad S
    Mol Pharm; 2018 Jan; 15(1):97-107. PubMed ID: 29164901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-amorphous formulation of dipyridamole with p-hydroxybenzoic acid: Underlying molecular mechanisms, physical stability, dissolution behavior and pharmacokinetic study.
    Guo W; Dong X; Li Y; Li C; Tian Y; Gao H; Li T; Zhu H; Wang J; Yang C
    Eur J Pharm Biopharm; 2023 Mar; 184():139-149. PubMed ID: 36709922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.